首页> 外文期刊>Brazilian Journal of Medical and Biological Research >New vaccine strategies against enterotoxigenic Escherichia coli: II: Enhanced systemic and secreted antibody responses against the CFA/I fimbriae by priming with DNA and boosting with a live recombinant Salmonella vaccine
【24h】

New vaccine strategies against enterotoxigenic Escherichia coli: II: Enhanced systemic and secreted antibody responses against the CFA/I fimbriae by priming with DNA and boosting with a live recombinant Salmonella vaccine

机译:针对肠毒素的大肠埃希氏菌的新疫苗策略:II:通过用DNA引发并用活的重组沙门氏菌疫苗加强免疫,增强了针对CFA / I菌毛的全身和分泌抗体反应

获取原文
           

摘要

The induction of systemic (IgG) and mucosal (IgA) antibody responses against the colonization factor I antigen (CFA/I) of enterotoxigenic Escherichia coli (ETEC) was evaluated in mice primed with an intramuscularly delivered CFA/I-encoding DNA vaccine followed by two oral immunizations with a live recombinant Salmonella typhimurium vaccine strain expressing the ETEC antigen. The booster effect induced by the oral immunization was detected two weeks and one year after the administration of the DNA vaccine. The DNA-primed/Salmonella-boosted vaccination regime showed a synergistic effect on the induced CFA/I-specific systemic and secreted antibody levels which could not be attained by either immunization strategy alone. These results suggest that the combined use of DNA vaccines and recombinant Salmonella vaccine strains can be a useful immunization strategy against enteric pathogens.
机译:在用肌肉注射CFA / I编码DNA疫苗引发的小鼠中评估了对肠毒素性大肠杆菌(ETEC)的定植因子I抗原(CFA / I)的全身(IgG)和粘膜(IgA)抗体应答的诱导用表达ETEC抗原的重组鼠伤寒沙门氏菌活疫苗株进行两次口服免疫。在施用DNA疫苗后两周零一年检测到口服免疫诱导的增强作用。 DNA引发的/沙门氏菌增强的疫苗接种方案对诱导的CFA / I特异性全身和分泌抗体水平显示出协同作用,这是任何一种免疫策略都无法达到的。这些结果表明,DNA疫苗和重组沙门氏菌疫苗菌株的联合使用可以作为针对肠道病原体的有效免疫策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号